Wan L. Lam

Active 1987–2024

116
Papers
20,117
Citations
81
h-index
113
i10-index

Citations

Citations per year for Wan L. Lam1989: 6 citations1990: 6 citations1991: 9 citations1992: 7 citations1993: 2 citations1994: 3 citations1995: 6 citations1996: 10 citations1997: 2 citations1998: 3 citations1999: 4 citations2000: 3 citations2001: 14 citations2002: 22 citations2003: 18 citations2004: 40 citations2005: 94 citations2006: 131 citations2007: 189 citations2008: 217 citations2009: 192 citations2010: 264 citations2011: 235 citations2012: 236 citations2013: 271 citations2014: 268 citations2015: 268 citations2016: 259 citations2017: 258 citations2018: 237 citations2019: 716 citations2020: 703 citations2021: 605 citations2022: 389 citations2023: 272 citations2024: 412 citations2025: 200 citations2026: 3 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,335 citing papers, 24.9% of this breakdownChina: 1,737 citing papers, 18.6% of this breakdownUnited Kingdom: 530 citing papers, 5.7% of this breakdownCanada: 465 citing papers, 5% of this breakdownGermany: 379 citing papers, 4% of this breakdownItaly: 298 citing papers, 3.2% of this breakdownFrance: 270 citing papers, 2.9% of this breakdownJapan: 263 citing papers, 2.8% of this breakdownSpain: 246 citing papers, 2.6% of this breakdownNetherlands: 217 citing papers, 2.3% of this breakdownIndia: 212 citing papers, 2.3% of this breakdownAustralia: 194 citing papers, 2.1% of this breakdown
0%24.9%Other 23.6%

Fields

  • Biochemistry, Genetics and Molecular Biology57.5%
  • Medicine29.2%
  • Immunology and Microbiology4.3%
  • Environmental Science2.3%
  • Agricultural and Biological Sciences1.8%
  • Dentistry1.5%
  • Other3.4%

Topics

  • Cancer-related molecular mechanisms research6.9%
  • RNA modifications and cancer5.9%
  • Epigenetics and DNA Methylation5.2%
  • MicroRNA in disease regulation3.2%
  • Circular RNAs in diseases2.6%
  • Cancer Genomics and Diagnostics2.6%
  • Other73.6%

Coauthors

All papers

Open in search
  1. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells

    Authors: , , , , , , - Nature Genetics 2005 cited by 1,754

  2. Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis

    Authors: , , , , , , , , , , , , , , , , , - Molecular Cancer 2016 cited by 260

  3. Genetic alterations defining NSCLC subtypes and their therapeutic implications

    Authors: , , , - Lung Cancer 2013 cited by 375

  4. Macrophages, Inflammation, and Lung Cancer

    Authors: , , , , , , - American Journal of Respiratory and Critical Care Medicine 2015 cited by 295

  5. The functional role of long non-coding RNA in human carcinomas

    Authors: , , - Molecular Cancer 2011 cited by 1,663

  6. Mechanisms Contributing to the Comorbidity of COPD and Lung Cancer

    Authors: , , , , , , , , , , - International Journal of Molecular Sciences 2023 cited by 107

  7. cGAS–STING and Cancer: Dichotomous Roles in Tumor Immunity and Development

    Authors: , , , - Trends in Immunology 2017 cited by 221

  8. Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2013 cited by 418

  9. CCL5 production in lung cancer cells leads to an altered immune microenvironment and promotes tumor development

    Authors: , , , , , , , , , , , , , , , , , , , , , - OncoImmunology 2021 cited by 65

  10. Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype

    Authors: , , , , , , , , , , , , , - Nature Medicine 2009 cited by 650

  11. Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression

    Authors: , , , , , , , , , , , , - Genome Research 2012 cited by 536

  12. The detection and implication of genome instability in cancer

    Authors: , , , - Cancer and Metastasis Reviews 2013 cited by 204

  13. Arsenic Exposure and the Induction of Human Cancers

    Authors: , , , , - Journal of Toxicology 2011 cited by 437

  14. Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Igor Jurišica, Colin Cooper, Rosalind A. Eeles, Melania Pintilie, Alan Dal Pra, Elai Davicioni, Wan L. Lam, Michael Milosevic, David E. Neal, Theodorus van der Kwast, Paul C. Boutros, Robert G. Bristow - The Lancet Oncology 2014 cited by 351

  15. Integrating copy number polymorphisms into array CGH analysis using a robust HMM

    Authors: , , , , , , - Bioinformatics, ISMB (Supplement of Bioinformatics) 2006 cited by 184

  16. Airway Aging and Methylation Disruptions in HIV-associated Chronic Obstructive Pulmonary Disease

    Authors: , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2022 cited by 47

  17. PIK3CA Mutations and Copy Number Gains in Human Lung Cancers

    Authors: , , , , , , , , , , , , , , , - Cancer Research 2008 cited by 432

  18. Environmental arsenic exposure: From genetic susceptibility to pathogenesis

    Authors: , , , , , , - Environment International 2017 cited by 216

  19. DNA Methylation Is Globally Disrupted and Associated with Expression Changes in Chronic Obstructive Pulmonary Disease Small Airways

    Authors: , , , , , , , , , , , , , , , , , - American Journal of Respiratory Cell and Molecular Biology 2013 cited by 156

  20. Piwi-interacting RNAs in cancer: emerging functions and clinical utility

    Authors: , , , , , , , - Molecular Cancer 2016 cited by 193

  21. Unique somatic and malignant expression patterns implicate PIWI-interacting RNAs in cancer-type specific biology

    Authors: , , , , , , , , , - Scientific Reports 2015 cited by 167

  22. Polycomb-mediated silencing in neuroendocrine prostate cancer

    Authors: , , , , , , , , , , - Clinical Epigenetics 2015 cited by 119

  23. Distinct bronchial microbiome precedes clinical diagnosis of lung cancer

    Authors: , , , , , - Molecular Cancer 2022 cited by 52

  24. Liquid Biopsy in Lung Cancer: Biomarkers for the Management of Recurrence and Metastasis

    Authors: , , , , , , , , , , , , , , , , - International Journal of Molecular Sciences 2023 cited by 32